Even though earlier reports from a cohort of 1,099 patients with COVID-19 from China showed that up to 39.4% had aspartate aminotransferase (AST) >40 U/L and 28.1% had Alanine aminotransferase (ALT) >40 U/L, most of these elevations occurred in critical COVID-19 cases (41). This evidence concerns the gene GPT and COVID-19.